SCHEMBL25453956

SCHEMBL25453956

CCC(C)(C)c1cccc(-c2ccc3c(c2)c2ccccc2n3-c2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ ATM Q13315 1/20 0.45
▸ TSPO P30536 2/20 0.41
▸ PTGER4 P35408 1/20 0.39
▸ SLC5A1 P13866 2/20 0.38
▸ SERPINE1 P05121 1/20 0.38
▸ NPY5R Q15761 2/20 0.37
▸ KMT2A Q03164 2/20 0.36
▸ MAPK8 P45983 1/20 0.36
▸ IL1R1 P14778 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ PPARG P37231 2/20 0.36
▸ MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18022256 0.88 L3MBTL1 (0.51) KDM4EL3MBTL1ATMTSPOPTGER4
SCHEMBL8739894 0.87 KDM4E (0.40) KDM4EL3MBTL1ATMTSPOSLC5A1
SCHEMBL8739895 0.87 KDM4E (0.40) KDM4EL3MBTL1ATMTSPOSLC5A1
SCHEMBL25752315 0.87 KDM4E (0.53) KDM4EL3MBTL1ATMPTGER4KMT2A
SCHEMBL14464635 0.86 TSPO (0.37) KDM4EL3MBTL1ATMTSPOSLC5A1
SCHEMBL24793867 0.86 KDM4E (0.49) KDM4EL3MBTL1ATMTSPOPTGER4
SCHEMBL13233024 0.84 KDM4E (0.39) KDM4EL3MBTL1ATMTSPOPTGER4
SCHEMBL19735293 0.84 RXRA (0.48) KDM4EL3MBTL1ATMTSPOSERPINE1
SCHEMBL14464662 0.84 KDM4E (0.42) KDM4EL3MBTL1ATMTSPOPTGER4
SCHEMBL22260288 0.84 KDM4E (0.47) KDM4EL3MBTL1ATMKMT2AMAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230146030-A1 ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230146030-A1 ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE OCIAD2, AOC2, OCIAD1 KDM4E 1366/4885L3MBTL1 4055/4885ATM 2496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback